Introduction The vasculitides include a broad spectrum of disorders that span a clinical spectrum from benign, self-limited disease to fulminant conditions that are fatal in the absence of therapy. Whereas the large-vessel vasculitides consist of 2 principal disorders, giant cell arteritis and Takayasu arteritis, the mediumand small-vessel vasculitides are much more diverse, including multiple diseases that can affect nearly every organ system. This article is the second of a 2-part series that focuses on the challenges faced by clinicians who care for patients with vasculitis. The first article in this series discussed the large-vessel vasculitides (1). The present article will examine the mediumand small-vessel vasculitides, reviewing the recent literature for insights regarding their epidemiology, pathogenesis, and treatment.
No takes yet. Share an insight, caveat, or question.
Seo et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: